Examination of the Effect of Nocturia on Pelvic Floor Symptoms, Sleep Parameters and Quality of Life in Women with Urinary Incontinence
Launched by GULHANE SCHOOL OF MEDICINE · Mar 4, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how waking up at night to urinate, known as nocturia, affects women who have urinary incontinence (UI). The researchers want to understand if nocturia impacts pelvic floor symptoms, sleep quality, tiredness, and overall quality of life in these women. Urinary incontinence is when someone accidentally leaks urine, which can be a frustrating and embarrassing issue. Nocturia can make this even harder because it disrupts sleep, leading to fatigue and other health problems.
To join the study, participants must be women aged 18 or older who have been diagnosed with urinary incontinence. Those who wake up at night to urinate and try to go back to sleep will be in one group, while those who don’t experience this will be in another group. Participants can expect to share information about their symptoms, sleep habits, and how they feel overall. This research is important because it could help improve the understanding and treatment of urinary incontinence and nocturia in women, ultimately enhancing their quality of life.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- Inclusion Criteria for the Group with Nocturia:
- • Being 18 years of age or older
- • Being female
- • Have been diagnosed with urinary incontinence
- • Wake up during the main sleep period to relieve the need to urinate, with the intention of returning to sleep or falling asleep again after each urination
- Inclusion Criteria for the Group without Nocturia:
- • Being 18 years of age or older
- • Being female
- • Have been diagnosed with urinary incontinence
- Exclusion Criteria:
- Exclusion Criteria for the Group with Nocturia:
- • Diagnosis of a sleep disorder
- • Diagnosis of any neurological disease
- • Chronic kidney disease
- • Diagnosis of diabetes
- • Use of sleep medications
- • Use of antidepressants
- • Use of diuretic medications
- • Use of any medication for urinary incontinence
- • Hormone replacement therapy
- • Pregnancy or having given birth within the last six months
- • Having had a urinary tract infection in the last three months
- • Presence of prolapse greater than stage 2
- • History of orthopedic trauma to the pelvic region
- • Pelvic surgery within the last six months
- • History of cancer
- Exclusion Criteria for the Group without Nocturia:
- • Waking up during the main sleep period to relieve the need to urinate, with the intention of returning to sleep or falling asleep again after each urination
- • Diagnosis of a sleep disorder
- • Diagnosis of any neurological disease
- • Chronic kidney disease
- • Diagnosis of diabetes
- • Use of sleep medications
- • Use of antidepressants
- • Use of diuretic medications
- • Use of any medication for urinary incontinence
- • Hormone replacement therapy
- • Pregnancy or having given birth within the last six months
- • Having had a urinary tract infection in the last three months
- • Presence of prolapse greater than stage 2
- • History of orthopedic trauma to the pelvic region
- • Pelvic surgery within the last six months
- • History of cancer
About Gulhane School Of Medicine
Gulhane School of Medicine is a prestigious medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in education and patient care, the school fosters a collaborative environment where multidisciplinary teams work to explore new treatment modalities and enhance medical knowledge. By engaging in rigorous clinical research, Gulhane School of Medicine aims to contribute to the development of effective therapies and improve health outcomes, ultimately benefitting both the local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Keçiören, Turkey
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported